Ignite Creation Date:
2025-12-24 @ 7:49 PM
Ignite Modification Date:
2026-05-17 @ 11:06 PM
Study NCT ID:
NCT05668403
Status:
RECRUITING
Last Update Posted:
2025-02-10
First Post:
2022-12-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy
Sponsor:
Organization: